Drugs / Euvax B Inj
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT02097004 | Apr 2014 → Jan 2018 | chronic hepatitis B virus infection | Seoul National University Hospital | Completed | Met primary |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Euvax B Inj | “HBV vaccination (Euvax B Inj): 1.0 mL (20 μg) intramuscular injection at 4, 8, 12 and 28 weeks” NCT02097004 ↗ |
| Modality | Vaccine | “HBV vaccination” NCT02097004 ↗ |
| Route | Intramuscular | “intramuscular injection” NCT02097004 ↗ |